{ "ok": true, "cik": "1663038", "ticker": "QTZM", "name": "Quantum Genesis AI Corp.", "filings": [ { "form": "10-Q", "filed": "2026-06-11", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1663038/000147793226003779/0001477932-26-003779-index.htm" }, { "form": "8-K", "filed": "2026-04-15", "items": [ "1.01 Entry into a Material Definitive Agreement", "8.01 Other Events", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1663038/000147793226002252/0001477932-26-002252-index.htm" }, { "form": "10-Q", "filed": "2026-03-19", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1663038/000147793226001481/0001477932-26-001481-index.htm" }, { "form": "8-K", "filed": "2026-02-13", "items": [ "5.03 Amendments to Articles or Bylaws; Change in Fiscal Year", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1663038/000147793226000821/0001477932-26-000821-index.htm" }, { "form": "8-K", "filed": "2026-01-07", "items": [ "5.03 Amendments to Articles or Bylaws; Change in Fiscal Year" ], "url": "https://www.sec.gov/Archives/edgar/data/1663038/000147793226000072/0001477932-26-000072-index.htm" }, { "form": "10-Q", "filed": "2025-12-15", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1663038/000147793225008968/0001477932-25-008968-index.htm" } ], "events12m": 3, "healthWatch": { "window": "last 12 months", "since": "2025-09-27", "signals": [ { "code": "NT 10-K", "label": "Late annual report notice", "count": 1, "latest": { "filed": "2025-10-28", "url": "https://www.sec.gov/Archives/edgar/data/1663038/000147793225007762/0001477932-25-007762-index.htm" } }, { "code": "NT 10-Q", "label": "Late quarterly report notice", "count": 1, "latest": { "filed": "2026-03-17", "url": "https://www.sec.gov/Archives/edgar/data/1663038/000147793226001371/0001477932-26-001371-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001663038.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1663038" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets and no trading recommendations.", "edgar": "🫧 Edgar looked up Quantum Genesis AI Corp. ($QTZM). Last filing: 10-Q, 2026-06-11. 3 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-07-31", "revenue": 0, "revenueGrowth1y": null, "revenueGrowthPerYear": null, "yearsOfData": 5, "operatingMargin": null, "operatingMarginPrior": null, "netMargin": null, "operatingCashFlow": -125181, "capitalSpending": null, "freeCashFlow": null, "researchAndDevelopment": null, "researchShareOfRevenue": null, "cash": 584, "longTermDebt": null, "longTermDebtChange": null, "revenueHistory": [ { "fiscalYearEnd": "2016-07-31", "revenue": 121327 }, { "fiscalYearEnd": "2017-07-31", "revenue": 128147 }, { "fiscalYearEnd": "2018-07-31", "revenue": 93550 }, { "fiscalYearEnd": "2024-07-31", "revenue": 0 }, { "fiscalYearEnd": "2025-07-31", "revenue": 0 } ], "totalEquity": -440717, "totalAssets": 584, "equityRatio": -754.652397260274, "returnOnEquity": null, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": -0.01, "sharesOutstanding": 35117811, "bookValuePerShare": -0.012549671732101982, "revenuePerShare": 0, "range80": null, "ifPaceHeld": null }, "edgarette": "🔖 Exposure: revenue $0K (FY2025). Experience: one year on record; operating margin null, up from null. Soundness: equity -75465.2% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Against peers (13 filers, $50M+ revenue, industrial organic chemicals): operating margin null against a -3.2% median.", "peers": { "sic": 2860, "sicDescription": "Industrial Organic Chemicals", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2860", "growth": [ -0.0355, 14 ], "opMargin": [ -0.0322, 13 ], "equityRatio": [ 0.5205, 12 ], "returnOnEquity": [ -0.0729, 10 ] }, "summary": "Quantum Genesis AI (QTZM) reported revenue of $0 million in FY2025, operating margin null against a -3.2% median for industrial organic chemicals, equity -75465% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
Quantum Genesis AI Corp. against its own record and its peers
Equity of assetsPeer median 52.0%-75465.2%Gold tick: the median of 12–12 peers with $50M+ revenue in industrial organic chemicals
", "chartHorizon": null, "backtest": { "tests": 0, "hits": 0, "rate": null, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Quantum Genesis AI (QTZM) reported revenue of $0 million in FY2025, operating margin null against a -3.2% median for industrial organic chemicals, equity -75465% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-07-31", "revenue": 0, "totalDebt": null, "cash": 584 }, "experience": { "revenueGrowth1y": null, "revenueGrowthPerYear": null, "operatingMargin": null, "operatingMarginPrior": null, "netMargin": null, "freeCashFlow": null }, "soundness": { "equityRatio": -754.652397260274, "returnOnEquity": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 2860, "sicDescription": "Industrial Organic Chemicals", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2860", "growth": [ -0.0355, 14 ], "opMargin": [ -0.0322, 13 ], "equityRatio": [ 0.5205, 12 ], "returnOnEquity": [ -0.0729, 10 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "healthWatch": { "window": "last 12 months", "since": "2025-09-27", "signals": [ { "code": "NT 10-K", "label": "Late annual report notice", "count": 1, "latest": { "filed": "2025-10-28", "url": "https://www.sec.gov/Archives/edgar/data/1663038/000147793225007762/0001477932-25-007762-index.htm" } }, { "code": "NT 10-Q", "label": "Late quarterly report notice", "count": 1, "latest": { "filed": "2026-03-17", "url": "https://www.sec.gov/Archives/edgar/data/1663038/000147793226001371/0001477932-26-001371-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "range": null, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001663038.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1663038" }, "speedCash": null, "harbor": { "signs": [ { "key": "warning", "text": "filed late annual report notice, late quarterly report notice in the last 12 months" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 1, "name": "Sound ship", "plain": "one warning sign" }, "cashFlow": { "fiscalYearEnd": "2025-07-31", "operating": -125181, "investing": null, "financing": 125765, "capitalSpending": null, "free": null, "trend": [ { "fiscalYearEnd": "2016-07-31", "operating": -3823, "free": null }, { "fiscalYearEnd": "2017-07-31", "operating": -38077, "free": null }, { "fiscalYearEnd": "2018-07-31", "operating": -2744, "free": -14644 }, { "fiscalYearEnd": "2024-07-31", "operating": -101637, "free": null }, { "fiscalYearEnd": "2025-07-31", "operating": -125181, "free": null } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-07-31", "cash": 584, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 584, "ladder": null, "currentRatio": 0, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same range method applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so.", "healthWatch": "Distress-type events the company filed in the last 12 months (late-filing notices; 8-K items 1.03, 3.01, 2.04, 4.02, 4.01, 2.05, 2.06, 1.05, 5.02), each with its count and newest filing. Display only: they do not change the range or its receipt." }, "speedCash": null, "harbor": { "signs": [ { "key": "warning", "text": "filed late annual report notice, late quarterly report notice in the last 12 months" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 1, "name": "Sound ship", "plain": "one warning sign" }, "cashFlow": { "fiscalYearEnd": "2025-07-31", "operating": -125181, "investing": null, "financing": 125765, "capitalSpending": null, "free": null, "trend": [ { "fiscalYearEnd": "2016-07-31", "operating": -3823, "free": null }, { "fiscalYearEnd": "2017-07-31", "operating": -38077, "free": null }, { "fiscalYearEnd": "2018-07-31", "operating": -2744, "free": -14644 }, { "fiscalYearEnd": "2024-07-31", "operating": -101637, "free": null }, { "fiscalYearEnd": "2025-07-31", "operating": -125181, "free": null } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-07-31", "cash": 584, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 584, "ladder": null, "currentRatio": 0, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }